2011 Biotechnology Research Review


January 1, 2012
207 Pages - SKU: WA6727977
License type:
Global Markets for Orphan Drugs – Focus on Biologics
6/1/2013 | published by: BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on  |  read more...
$4,400.00
Global Markets for Orphan Drugs – Focus on Non-Biologics
6/1/2013 | published by: BCC Research
This report provides: An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on  |  read more...
$4,400.00
Antibody Drug Conjugates Market, 2012-2023
5/31/2013 | published by: Roots Analysis Pvt. Ltd.
Antibody Drug Conjugates (ADC) are a new class of biologic therapeutics. These are complex molecules comprising of an antibody linked to few cytotoxin molecules through linker technology. This class of biologics is attracting the attention  |  read more...
$1,699.00
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013
5/27/2013 | published by: GlobalData
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData’s PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013, provides strategic analysis of the global biosimilars  |  read more...
$2,995.00
Pharmaceutical Market India: A Comprehensive Industry Analysis
5/20/2013 | published by: Kelly Scientific Publications
Pharmaceutical Market India: A Comprehensive Industry Analysis provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report, Pharmaceutical Market India:  |  read more...
$2,620.00
Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A
5/20/2013 | published by: Renub Research
The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to  |  read more...
$1,600.00
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
5/14/2013 | published by: GBI Research
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific Summary GBI Research, the leading business intelligence provider, has released its latest research, “Critical Care Market to 2019  |  read more...
$3,500.00
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
5/16/2013 | published by: Kelly Scientific Publications
BioPharmaceutical Industry in China provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report, BioPharmaceutical Industry in China - An  |  read more...
$2,620.00
Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3
5/1/2013 | published by: Current Partnering
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in  |  read more...
$1,995.00
Post-Patent Generic and Biosimilar Defense Strategies
4/1/2013 | published by: Cutting Edge Information
Post-Patent Generic and Biosimilar Defense Strategies Create Robust Counter-Generics Strategies to Maximize Market Share As Patents Expire Fresh off of 2012’s patent cliff, the life sciences industry is bracing for a second  |  read more...
$7,695.00